ITPC Afrique du Nord

Nouveautés sur le Web

• 18 juin – Over half of people living with AIDS in San Francisco are aged 50 or older
• 17 juin – Hyaluronic acid levels can predict risk of serious liver events in people living with HIV and hepatitis B or C co-infection
• 14 juin – PrEP works for injecting drug users too
• 13 juin – Sexual health information is often inappropriate for Facebook sharing, say young people
• 12 juin – Mobile phone support increases chances that people living with HIV will quit smoking
• 12 juin – Low CD4 cell count increases the risk of several cancers after starting HIV therapy
• 11 juin – Undetectable viral load reduces the risk of HIV-associated anal cancer
• 10 juin – High rate of spontaneous disease regression in men with high-grade pre-cancerous anal lesions
• 10 juin – Intimate partner violence associated with subsequent HIV infection in Uganda
• 7 juin – Combination prevention could "eliminate" HIV transmissions in Vietnam, model projects
• 7 juin – Female sex workers frequently offered larger fees by their clients in return for sex without a condom
• 6 juin – High rates of gonorrhoea among people living with HIV in the US
• 5 juin – 2012: half a million sexually transmitted infections in England
• 5 juin – People doing well on HIV therapy have a mortality risk identical to that of HIV-negative peers
• 4 juin – Campaign approach increases enrolment of pregnant women on ART in South Africa
• 3 juin – Nevirapine dose escalation for children may risk treatment failure
• 31 mai – Community viral load is flawed indicator of infectiousness, say experts
• 31 mai – HIV cure: the long road ahead
• 30 mai – 'War on drugs' fuelling the hepatitis C epidemic among people who inject drugs
• 29 mai – Deciding what’s risky – Australian gay men pay more attention to the sexual act than to their partner’s HIV status or viral load
• 28 mai – Hepatitis C treatment gap in Europe: France doing well but Italy treated fewer than one in a hundred patients in 2010
• 24 mai – Small fall in new HIV diagnoses in London, but rate of new diagnoses among gay men continues to increase
• 23 mai – Expanded access to HIV treatment achieves big falls in mortality rates in China
• 22 mai – AZT associated with poorer immunological recovery in people taking first-line HIV treatment in southern Africa
• 21 mai – Majority of Italian HIV specialists would prescribe PrEP
• 20 mai – Case workers can re-engage a high proportion of HIV-positive people lost to long-term care
• 18 mai – Higher rates of HIV in US black gay men may be due to smaller choice of partners and more age mixing
• 16 mai – Dramatic improvements in HIV testing are possible – local leadership and multiple initiatives required
• 16 mai – Triple therapy for hepatitis C is effective after liver transplantation, but side-effects are common
• 16 mai – Engagement with health care leads to more prompt HIV diagnosis and higher rates of virological suppression among gay men
• 15 mai – Hepatitis E virus infection can cause rapid liver cirrhosis in people with HIV who have low CD4 cell counts
• 14 mai – More drugs, more alcohol often means more risky sex for HIV-negative gay men
• 13 mai – People more likely to keep HIV clinic appointments if they believe their care providers know them as a person
• 11 mai – New HCV combinations could have a big role in prevention, but only if treatment rates increase
• 10 mai – Up to a third of HIV infections in European gay men may have come from another country
• 9 mai – Movement for global access to hepatitis C treatment building momentum
• 9 mai – Herpes viruses associated with shedding of HIV in the semen of gay men taking suppressive antiretroviral therapy
• 7 mai – Report highlights major failings in UK response to hepatitis C
• 7 mai – High prevalence of oral HPV infection in Dutch gay men
• 2 mai – Daclatasvir + asunaprevir + BMS-791352 looks promising as interferon-free combination
• 1er mai – Blackmail, violence and stigma restrict access to sexual health services for gay men, Global Health and Rights Study reports
• 30 avril – Compassionate access to new hepatitis C drugs an "emergency" for European patients
• 30 avril – Les rapports de la consultation les défis de la mise en oeuvre du traitement comme prévention (TasP) - 30/04/2013
• 30 avril – Second-generation HCV protease inhibitor simeprevir pushes triple therapy cure rate up to 80%
• 30 avril – Second-generation protease inhibitor faldaprevir cures up to 80% of hepatitis C
• 30 avril – Triple-drug HCV therapy comes with high risk of serious adverse events for people with cirrhosis
• 29 avril – Hep C quad regimens quashed, but some components go forward
• 29 avril – Daclatasvir + sofosbuvir offers hepatitis C rescue therapy after current standard of care
• 29 avril – A majority of HIV-positive gay men in Dutch survey take their viral load into consideration if having unprotected sex
• 26 avril – Researchers stop the only current HIV vaccine efficacy trial
• 26 avril – AbbVie interferon-free combination cures over 90% of hepatitis C genotype 1
• 26 avril – Sofosbuvir + ribavirin cures most genotype 2 hepatitis C, but genotype 3 response is lower
• 25 avril – Consistent decline in partner numbers in US gay men in last decade, but no change in condom use
• 24 avril – Genetics make a large contribution to cardiovascular risk for people with HIV
• 23 avril – For African women in the UK, formula feeding has a high social and personal cost
• 23 avril – Some barriers to adherence for black African people in London are culturally specific
• 22 avril – London HIV drug prescribing changes – patient satisfaction and clinical outcomes maintained
• 22 avril – Training for GPs can increase HIV testing rate
• 18 avril – Elevated prevalence of HIV and viral hepatitis in men injecting anabolic steroids
• 18 avril – England: health and wellbeing boards not prioritising HIV